Terms: = Pancreatic cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
365 results:
1. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
[TBL] [Abstract] [Full Text] [Related]
2. Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets.
Banesh S; Patil N; Chethireddy VR; Bhukmaria A; Saudagar P
Med Oncol; 2024 Mar; 41(5):90. PubMed ID: 38522058
[TBL] [Abstract] [Full Text] [Related]
3. A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses.
Zhang S; Qin O; Wu S; Xu H; Huang W; Hailiang S
Aging (Albany NY); 2024 Mar; 16(6):5545-5566. PubMed ID: 38517376
[TBL] [Abstract] [Full Text] [Related]
4. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
[TBL] [Abstract] [Full Text] [Related]
5. Screening of genes characteristic of pancreatic cancer by LASSO regression combined with support vector machine and recursive feature elimination, and immune correlation analysis.
Zeng L; Chen Z
J Int Med Res; 2024 Mar; 52(3):3000605241233160. PubMed ID: 38456653
[TBL] [Abstract] [Full Text] [Related]
6. Construction of individualised care programmes for patients with pancreatic cancer with postoperative weight-loss control based on the Delphi method: a cross-sectional study in China.
Chen L; Huang Z; Tian Q; Zha Q; Zhang S; Chen Z; Dong Z; Zhou Y; Zhang M; Wei X
J Health Popul Nutr; 2024 Mar; 43(1):36. PubMed ID: 38429793
[TBL] [Abstract] [Full Text] [Related]
7. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract] [Full Text] [Related]
8. AMIGO2 is a pivotal therapeutic target related to M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Chen S; Du W; Feng K; Liu K; Li C; Li S; Yin H
Aging (Albany NY); 2024 Jan; 16(2):1111-1127. PubMed ID: 38189855
[TBL] [Abstract] [Full Text] [Related]
9. Aneuploidy Landscape in Precursors of Ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
10. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival.
Wang L; Wu Z; Xu C; Ye H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18119-18134. PubMed ID: 38007403
[TBL] [Abstract] [Full Text] [Related]
11. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation.
Xu Y; Wang Y; Chen Q; Yao T; Qiu J; Ni L; Chen H; Liang T
Pancreatology; 2023 Dec; 23(8):1003-1013. PubMed ID: 37923686
[TBL] [Abstract] [Full Text] [Related]
12. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study.
Jiaao L; Wanli G; Kai Z; Feng G; Yunpeng P
Eur J Med Res; 2023 Oct; 28(1):436. PubMed ID: 37848965
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning.
Yuan Z; Shu Z; Peng J; Wang W; Hou J; Han L; Zheng G; Wei Y; Zhong J
Abdom Radiol (NY); 2024 Jan; 49(1):117-130. PubMed ID: 37819438
[TBL] [Abstract] [Full Text] [Related]
14. Early diagnosis of pancreatic cancer via Machine Learning Analysis of a National Electronic Medical Record Database.
Matchaba S; Fellague-Chebra R; Purushottam P; Johns A
JCO Clin Cancer Inform; 2023 Sep; 7():e2300076. PubMed ID: 37816199
[TBL] [Abstract] [Full Text] [Related]
15. Automated Artificial Intelligence Model Trained on a Large Data set Can Detect Pancreas cancer on Diagnostic Computed Tomography Scans As Well As Visually Occult Preinvasive cancer on Prediagnostic Computed Tomography Scans.
Korfiatis P; Suman G; Patnam NG; Trivedi KH; Karbhari A; Mukherjee S; Cook C; Klug JR; Patra A; Khasawneh H; Rajamohan N; Fletcher JG; Truty MJ; Majumder S; Bolan CW; Sandrasegaran K; Chari ST; Goenka AH
Gastroenterology; 2023 Dec; 165(6):1533-1546.e4. PubMed ID: 37657758
[TBL] [Abstract] [Full Text] [Related]
16. Association between sodium-glucose cotransporter 2 inhibitors and pancreatic cancer in the Japanese working-age population.
Tanaka Y; Yokoyama S; Nakagawa C; Uno T; Hosomi K
Int J Clin Pharmacol Ther; 2023 Nov; 61(11):492-502. PubMed ID: 37644877
[TBL] [Abstract] [Full Text] [Related]
17. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation.
Xu J; Quan G; Huang W; Jiang J
Cell Commun Signal; 2023 Aug; 21(1):223. PubMed ID: 37626304
[TBL] [Abstract] [Full Text] [Related]
18. Radiomics model versus 2017 revised international consensus guidelines for predicting malignant intraductal papillary mucinous neoplasms.
Lee DY; Shin J; Kim S; Baek SE; Lee S; Son NH; Park MS
Eur Radiol; 2024 Feb; 34(2):1222-1231. PubMed ID: 37615762
[TBL] [Abstract] [Full Text] [Related]
19. Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.
Wang W; Tian X; Yan L; Guan X; Dong B; Zhao M; Liu D; Wu J; Hao C
Ann Med; 2023; 55(2):2242247. PubMed ID: 37544888
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Predicting Model of pancreatic Body Tail Carcinoma Using Clinical and CT Radiomic Data.
An P; Lin Y; Zhang J; Hu Y; Qin P; Ye Y; Li X; Feng G; Wang J
Technol Cancer Res Treat; 2023; 22():15330338231186739. PubMed ID: 37464839
[No Abstract] [Full Text] [Related]
[Next]
